5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The Hemodynamic Monitoring Market is segmented by System (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, Non-invasive Monitoring Systems), Application, and Geography
2018 - 2026
Fastest Growing Market:
The global hemodynamic monitoring market is expected to grow with a CAGR of 3.85% in the forecasted period. The key factors propelling the growth of this market are increase in the number of critically ill geriatric cases, rise in the prevalence of cardiac disorders and diabetes, increasing demand for home-based and non-invasive monitoring systems, advances in technology, due to funding by private players and government bodies, and increase in the number of people suffering from hypertension.
As per the scope of the report, critically ill patients require continuous monitoring of their vital parameters. This is done by direct pressure monitoring systems, which are also known as hemodynamic systems. The main function of these systems is to monitor the cardiac activity. The hemodynamic systems give information about blood pressure, blood volume, and fluid balance.
Report scope can be customized per your requirements. Click here.
In the system segment of the market, minimally invasive monitoring systems are believed to have the largest market size and are expected to witness a CAGR of 8.0% during the forecast period.
The minimally invasive systems help in tracking stroke volume continuously and offer dynamic information of fluid responsiveness. Some of the systems provide the assessment of volumetric preload variables, while others highlight the continuous measurement of central venous saturation with proprietary catheters. These variables of minimally invasive systems, along with cardiac output, deliver improved hemodynamic monitoring.
There is a recent advancement in echocardiography device known as a transesophageal echocardiography device with a miniaturized probe, which is now used for continuous hemodynamic assessment. These monitoring systems have made hemodynamic calculations easier, which has gained the attention of healthcare providers, thus, resulting in the growth of the market.
To understand key trends, Download Sample Report
North America currently dominates the market for hemodynamic monitoring and is expected to continue its stronghold for a few more years. The United States holds the largest share of the global hemodynamic monitoring market. The growth of the US hemodynamic monitoring market is the most notable, owing to the presence of major market players, technologically advanced hospitals, and an increasing number of critically ill patients being treated in hospitals of the region. In 2016, Cheetah Medical Inc. received FDA approval for ‘Starling SV’, a non-invasive hemodynamic monitoring system.
With increasing FDA approvals for monitoring devices and new product launches, the US hemodynamic monitoring market is expected to grow during the forecast period.
To understand geography trends, Download Sample Report.
The hemodynamic monitoring market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new devices with fewer prices. Companies, like Getinge Group, Koninklijke Philips NV, Edwards Life Sciences Corporation, GE Healthcare, and LiDCO Group, hold substantial shares in the market.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Critically Ill Geriatric Population
4.2.2 Rise in the Prevalence of Cardiac Disorders and Diabetes
4.2.3 Increasing Demand for Home-based and Non-invasive Monitoring Systems
4.2.4 Advances in Technology due to Funding by Private Players and Government Bodies
4.2.5 Increasing Number of People Suffering from Hypertension
4.3 Market Restraints
4.3.1 Increasing Incidences of Complications Associated with Invasive Monitoring Systems
4.3.2 Stringent FDA Guidelines for Approval of New Systems
4.3.3 Precision of CO Determinations Adversely Affected Under Low Flow Conditions
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By System
5.1.1 Minimally Invasive Monitoring Systems
5.1.2 Invasive Monitoring Systems
5.1.3 Non-invasive Monitoring Systems
5.2 By Application
5.2.1 Laboratory-based Monitoring Systems
5.2.2 Home-based Monitoring Systems
5.2.3 Hospital-based Monitoring Systems
5.3.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.3.4 Middle East & Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle East & Africa
5.3.5 South America
184.108.40.206 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 LiDCO Group PLC
6.1.2 Cheetah Medical Inc.
6.1.3 ICU Medical Inc.
6.1.4 Tensys Medical Inc.
6.1.5 Schwarzer Cardiotek GmbH
6.1.6 Koninklijke Philips NV
6.1.7 Edwards Lifesciences Corporation
6.1.8 Getinge Group
6.1.9 GE Healthcare
6.1.10 Draeger Medical
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments